Inventor

DRUZGALA PASCAL

US57 patents

⚠️ This page may combine multiple inventors who share the name “DRUZGALA PASCAL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DRUZGALA PASCAL

ARYX THERAPEUTICS

Materials and methods for the treatment of depression

Compound for treatment of cardiac arphythmia, synthesis, and methods of use

Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use

Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use

Compounds for treatment of cardiac arrhythmia synthesis, and methods of use

Long-acting local anesthetics

Materials and methods for the treatment of gastroesophageal reflux disease

Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders

Materials and methods for treating coagulation disorders

5-HT3 receptor antagonists and methods of use

5-HT3 receptor antagonists and methods of use

Compounds for treatment of cardiac arrhythmia, synthesis, and methods of use

Ultrashort acting hypnotic barbiturates

Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use

Ultrashort acting hypnotic barbiturates

Materials and methods for treating coagulation disorders

Materials and methods for treating coagulation disorders

Compounds for treatment of cardiac arrhythmia, synthesis, and methods of use

Materials and methods for the treatment of depression

Ultrashort-acting opioids for transdermal application

Antiarrhythmic precursor compounds, methods of synthesis and methods of use

Materials and methods for treating coagulation disorders

Materials and methods for the treatment of hypertension and angina

Ultrashort-acting opioids for transdermal application

Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use

ARYX THERAPEUTICS INC

Compound for treatment of cardiac arrhythmia, synthesis, and methods of use

Compounds for treatment of cardiac arrhythmia and methods of use

Ultrashort acting hypnotic barbiturates

Compounds for treatment of cardiac arrhythmia, synthesis, and methods of use

Ultrashort-acting opioids for transdermal applications

Materials and methods for treating hypercholesterolemia

Halogenated ester derivatives of coumarins for the treatment of coagulation disorders

Haloalkyl ester derivatives of coumarin for the treatment of coagulation disorders

Materials and methods for the treatment of gastroesophageal reflux disease

Ultrashort acting hypnotic barbiturates

5-HT3 receptor antagonists and methods of use

Materials and methods for treating hypercholesterolemia

Compounds for treatment of cardiac arrhythmia and methods of use

Materials and methods for the treatment of diabetes, hyperlipidemia, hypercholesterolemia, and atherosclerosis

Xyra LLC

Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations

Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations

Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations

Cardioversion methods using budiodarone

Methods for reducing the risk of heart failure or strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations

Methods for reducing the risk of strokes by pharmacotherapy to reduce the number and duration of atrial fibrillations

ADVANCED THERAPIES INC

Compound for treatment of cardiac arrhythmia, synthesis, and methods of use

Compound for treatment of cardiac arrhythmia, synthesis, and methods of use

IRWIN IAN

Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders

LUEHR GARY W

D2 antagonists, methods of synthesis and methods of use